Compare State Street SPDR S&P Biotech ETF (XBI) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.43, while Direxion Daily FTSE China Bull 3x Shares trades at $27.9. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| XBI | YINN | |
|---|---|---|
Sector | Broad Market / Factor | Leveraged / Inverse |
52-Week High | $164.28 | $56.62 |
52-Week Low | $85.16 | $21.45 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
